JP6792079B2 - 1つまたは複数の異なるドーピング要素を含むポリマー材料、利用法、および製造方法 - Google Patents
1つまたは複数の異なるドーピング要素を含むポリマー材料、利用法、および製造方法 Download PDFInfo
- Publication number
- JP6792079B2 JP6792079B2 JP2019531531A JP2019531531A JP6792079B2 JP 6792079 B2 JP6792079 B2 JP 6792079B2 JP 2019531531 A JP2019531531 A JP 2019531531A JP 2019531531 A JP2019531531 A JP 2019531531A JP 6792079 B2 JP6792079 B2 JP 6792079B2
- Authority
- JP
- Japan
- Prior art keywords
- polymer material
- polymer
- material according
- polymeric material
- doping element
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims description 67
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 239000002861 polymer material Substances 0.000 claims description 31
- 229920000642 polymer Polymers 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 25
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 18
- 230000005670 electromagnetic radiation Effects 0.000 claims description 14
- 239000002657 fibrous material Substances 0.000 claims description 14
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 7
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 229920000889 poly(m-phenylene isophthalamide) Polymers 0.000 claims description 4
- 229920003366 poly(p-phenylene terephthalamide) Polymers 0.000 claims description 4
- -1 polyethylene terephthalate Polymers 0.000 claims description 4
- 229910000640 Fe alloy Inorganic materials 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 230000008021 deposition Effects 0.000 claims description 2
- 238000001523 electrospinning Methods 0.000 claims description 2
- OJQSISYVGFJJBY-UHFFFAOYSA-N 1-(4-isocyanatophenyl)pyrrole-2,5-dione Chemical compound C1=CC(N=C=O)=CC=C1N1C(=O)C=CC1=O OJQSISYVGFJJBY-UHFFFAOYSA-N 0.000 claims 1
- 101001099381 Homo sapiens Peroxisomal biogenesis factor 19 Proteins 0.000 claims 1
- 102100038883 Peroxisomal biogenesis factor 19 Human genes 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 29
- 210000004088 microvessel Anatomy 0.000 description 28
- 230000004089 microcirculation Effects 0.000 description 22
- 229910052760 oxygen Inorganic materials 0.000 description 21
- 239000001301 oxygen Substances 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 21
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 20
- 238000005259 measurement Methods 0.000 description 19
- 210000003743 erythrocyte Anatomy 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 18
- 230000005855 radiation Effects 0.000 description 15
- 239000008280 blood Substances 0.000 description 14
- 210000000601 blood cell Anatomy 0.000 description 13
- 210000002027 skeletal muscle Anatomy 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 11
- 229910045601 alloy Inorganic materials 0.000 description 11
- 239000000956 alloy Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 239000000902 placebo Substances 0.000 description 11
- 229940068196 placebo Drugs 0.000 description 11
- 210000000056 organ Anatomy 0.000 description 10
- 244000309466 calf Species 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 210000000264 venule Anatomy 0.000 description 7
- 229910000859 α-Fe Inorganic materials 0.000 description 7
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- 230000007124 immune defense Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000004087 circulation Effects 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- 102000008015 Hemeproteins Human genes 0.000 description 4
- 108010089792 Hemeproteins Proteins 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 210000002565 arteriole Anatomy 0.000 description 4
- 210000001736 capillary Anatomy 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 210000004180 plasmocyte Anatomy 0.000 description 4
- 230000000069 prophylactic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- 208000005230 Leg Ulcer Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000013544 Platelet disease Diseases 0.000 description 2
- 208000013201 Stress fracture Diseases 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000019501 erythrocyte disease Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 238000009207 exercise therapy Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003701 histiocyte Anatomy 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229910015136 FeMn Inorganic materials 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 229910000979 O alloy Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- JQRLYSGCPHSLJI-UHFFFAOYSA-N [Fe].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 Chemical compound [Fe].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JQRLYSGCPHSLJI-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003923 mental ability Effects 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000002956 necrotizing effect Effects 0.000 description 1
- 238000009828 non-uniform distribution Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
- A43B17/14—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined made of sponge, rubber, or plastic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/022—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the choice of material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/05—Filamentary, e.g. strands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/07—Flat, e.g. panels
- B29C48/08—Flat, e.g. panels flexible, e.g. films
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/14—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the particular extruding conditions, e.g. in a modified atmosphere or by using vibration
- B29C48/142—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the particular extruding conditions, e.g. in a modified atmosphere or by using vibration using force fields, e.g. gravity or electrical fields
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/25—Component parts, details or accessories; Auxiliary operations
- B29C48/285—Feeding the extrusion material to the extruder
- B29C48/295—Feeding the extrusion material to the extruder in gaseous form
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
- C08J3/21—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
- C08J3/21—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
- C08J3/212—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase and solid additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/04—Reinforcing macromolecular compounds with loose or coherent fibrous material
- C08J5/10—Reinforcing macromolecular compounds with loose or coherent fibrous material characterised by the additives used in the polymer mixture
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/02—Polyesters derived from dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
- C08L77/06—Polyamides derived from polyamines and polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/60—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing iron, cobalt or nickel
- C09K11/602—Chalcogenides
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D1/00—Treatment of filament-forming or like material
- D01D1/06—Feeding liquid to the spinning head
- D01D1/065—Addition and mixing of substances to the spinning solution or to the melt; Homogenising
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/106—Radiation shielding agents, e.g. absorbing, reflecting agents
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
- D01F6/60—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyamides
- D01F6/605—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyamides from aromatic polyamides
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
- D01F6/62—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B1/00—Footwear characterised by the material
- A43B1/0027—Footwear characterised by the material made at least partially from a material having special colours
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B23/00—Uppers; Boot legs; Stiffeners; Other single parts of footwear
- A43B23/02—Uppers; Boot legs
- A43B23/0205—Uppers; Boot legs characterised by the material
- A43B23/0215—Plastics or artificial leather
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
- B29K2067/003—PET, i.e. poylethylene terephthalate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2077/00—Use of PA, i.e. polyamides, e.g. polyesteramides or derivatives thereof, as moulding material
- B29K2077/10—Aromatic polyamides [polyaramides] or derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
- B29K2105/0035—Medical or pharmaceutical agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2509/00—Use of inorganic materials not provided for in groups B29K2503/00 - B29K2507/00, as filler
- B29K2509/02—Ceramics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0003—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds having particular electrical or magnetic properties, e.g. piezoelectric
- B29K2995/0011—Electromagnetic wave shielding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/48—Wearing apparel
- B29L2031/50—Footwear, e.g. shoes or parts thereof
- B29L2031/507—Insoles
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
- C08J2367/02—Polyesters derived from dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2377/00—Characterised by the use of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Derivatives of such polymers
- C08J2377/10—Polyamides derived from aromatically bound amino and carboxyl groups of amino carboxylic acids or of polyamines and polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2265—Oxides; Hydroxides of metals of iron
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2265—Oxides; Hydroxides of metals of iron
- C08K2003/2272—Ferric oxide (Fe2O3)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/002—Physical properties
- C08K2201/005—Additives being defined by their particle size in general
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/011—Nanostructured additives
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/02—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides
- D10B2331/021—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides aromatic polyamides, e.g. aramides
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/04—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET]
- D10B2331/042—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET] aromatic polyesters, e.g. vectran
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Mechanical Engineering (AREA)
- Textile Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Radiation-Therapy Devices (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
- Bedding Items (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
- Artificial Filaments (AREA)
- Woven Fabrics (AREA)
Description
a.適切な溶解したポリマーを準備し、
b.適切なドーピング要素を準備し、
c.ステップb)で準備したドーピング要素を適切な方法によって蒸発させ、ステップa)で準備した溶解したポリマーに蒸発したドーピング要素を入れ、
d.本発明によるポリマー材料を電界の中で押出成形する。
a.適切な溶解したポリマーを準備し、
b.適切なドーピング要素を準備し、
c.ステップb)で準備したドーピング要素を適切な方法によって蒸発させ、ステップa)で準備した溶解したポリマーに蒸発したドーピング要素を入れ、
d.本発明によるポリマー材料を電界の中で押出成形する。
本発明によるドーピング要素、たとえばSrFe12O19−合金(SrO(γFe2O3)6)を、好ましくはプラズマ真空蒸着テクノロジーを用いて金属熱分解式に蒸発させる。発生するガスを注入によって適切な量の溶解したポリマーに、好ましくはポリエステルに、特にポリエチレンテレフタレートまたはポリアミドに入れる。電界を印加することで、たとえば本発明によるポリマー材料ファイバを紡糸する。そのためにEスピニング法を適用するのが好ましく、この場合、蒸発したドーピング要素が入っている溶解したポリマーの液滴に線材が通される。この線材の直径と長さは、磁石から溶解したポリマーまでの距離と、電界の強さとによって規定される。
B.1:プラシーボ対照のための対照靴中敷
以下に説明する二重盲検式のプラシーボ対照実験のために、本発明によるポリマー材料を吸収層として含んでおらず、本発明による靴中敷に構造面で対応させるために上側材料を事後穿孔した、市販品として入手できるECCO社の標準靴中敷を使用した。
以下に説明する二重盲検式のプラシーボ対照実験のために、構造に関して前述の対照靴中敷と同等である本発明による靴中敷を使用し、吸収層は本発明によるポリマー材料(例Aを参照)を含んでおり、穿孔された上側材料で覆われている(B1に基づく対照靴中敷を参照)。
C.1:実験のデザイン
十分に均一なそれぞれn=18の4つの副標本に区分された(それぞれ男性の被験者9名、女性の被験者9名)、全標本Nges=72の被験者について調べた。
実験は盲検式に行った。各々の副標本に含まれる各々の被験者が2つの実験シリーズに参加した。すなわち、プラシーボ靴中敷(対照)の使用と、本発明による靴中敷(Verum)の使用である。両方の実験シリーズの間に2〜3週間の時間インターバルをおいた。対照の実験シリーズまたはVerumの実験シリーズへの各々の被験者の参加の順序は、乱数発生器によって決めた。
−微小血管における赤血球の流動QRBC
−微小血管網における赤血球の平均流速VRsc
−微小血管における相対的なヘモグロビン飽和度rHb
−定義された血管網で血球灌流される結節点の数nNP
−ターゲット組織の微小循環における細静脈側の酸素摂取率ΔPO2
測定時点:
0日目に初期値を測定し、1日目から30日目まで毎日、循環ベルト負荷の前と後に測定を行った。
微小循環の機能状態に関して検査した特別な靴中敷の治療結果の医学的判断にとって格段の意義があるのが、微小血管における赤血球の平均流動QRBC、微小血管網で血球灌流される結節点の数nNP、および、活性筋肉組織における細静脈側の酸素摂取率ΔPO2の指標である。
図1は、副標本A,B,CおよびDの被験者/患者の左ふくらはぎの骨格筋の微小血管網における赤血球の平均流動QRBCの指標に関する測定データ(平均値と標準偏差)を、対照とVerum(平均値と標準偏差)について示す。縦軸:単位パーセントでの指標変化(初期値との比較)。横軸:30日の実験期間中の測定日。
図2は、副標本A,B,CおよびDの被験者/患者の左ふくらはぎの微小血管網における血球灌流される結節点の数nNPの指標に関する測定データ(平均値と標準偏差)を、対照とVerum(平均値と標準偏差)について示す。縦軸:単位パーセントでの指標変化(初期値との比較)。横軸:30日の実験期間中の測定日。
図3は、副標本A,B,CおよびDの被験者/患者の左ふくらはぎの骨格筋の微小血管網における細静脈側の酸素摂取率ΔPO2の指標に関する測定データ(平均値と標準偏差)を、対照とVerum(平均値と標準偏差)について示す。縦軸:単位パーセントでの指標変化(初期値との比較)。横軸:30日の実験期間中の測定日。
図5Aおよび図5Bは、実験の実施前(図5A)と、実験の30日目における本発明による靴中敷の適用後(図5B)における、Verum群の年配の糖尿病患者(副標本D)の生体顕微鏡検査の所見例を示す。示されているのは左ふくらはぎの皮下組織の一領域である(毛細血管、細動脈、細静脈)。
事前(0日目の初期条件)
事後(本発明による靴中敷の適用後30日目の分布状態)
図5Aおよび図5Bの図像から、血球灌流される微小血管の明らかな増加、およびこれに伴う微小循環予備量の拡大を認めることができる。
対照とVerumについての副標本A,B,CおよびDの被験者/患者の左ふくらはぎの骨格筋の微小血管網における赤血球の平均流速VRscの指標に関する測定データは、驚くべきことに、赤血球が血漿よりも最大で係数1.4だけ速く流れることを示している。
Claims (4)
- 1つまたは複数の異なるドーピング要素を含むポリマー材料を製造する方法において、
1つのドーピング要素または異なるドーピング要素のうちの少なくとも1つが、脊椎動物から放出される電磁放射を少なくとも部分的に吸収し、赤外領域の電磁放射を少なくとも部分的に放出し、
前記方法は次の各ステップを含み、またはこれらで構成され、
a.適切な溶解したポリマーを準備し、ここで、前記ポリマーは、ポリエステル、たとえばポリエチレンテレフタレート(PET)の群と、ポリアミド、たとえばポリ(p−フェニレンテレフタルアミド)(PPTA)およびポリ(m−フェニレンイソフタルアミド)(PMPI)の群とで構成されるリストから選択され、
b.適切なドーピング要素を準備し、ここで、前記1つのドーピング要素または異なるドーピング要素のうちの少なくとも1つが鉄合金を含み、
c.前記ステップb)で準備したドーピング要素を適切な方法によって蒸発させ、前記ステップa)で準備した溶解したポリマーに蒸発したドーピング要素を入れ、
d.前記ポリマー材料を電界の中で押出成形することを特徴とする方法。 - 前記ステップc)でドーピング要素がプラズマ蒸着テクノロジー(PVD)で気化されて前記ポリマーの溶液中に析出され、および/もしくは前記ステップd)で前記ポリマー材料がエレクトロ・スピニング・テクノロジーによって押し出され、ならびに/または1つもしくは複数の前記方法ステップが滅菌された条件のもとで、および/もしくは真空中で実行されることを特徴とする、請求項1に記載のポリマー材料を製造する方法。
- ドーピング要素が1〜10nmのサイズで前記ポリマー材料に埋設され、前記ポリマー材料がドーピング要素をポリマー材料表面に対して絶縁することを特徴とする、請求項1または2に記載のポリマー材料を製造する方法。
- 前記ポリマー材料がファイバもしくはフィルムとして押し出され、または、他の繊維材料が少なくとも部分的に前記ポリマー材料でコーティングされることを特徴とする、請求項1から3のいずれか1項に記載のポリマー材料を製造する方法。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2016/069816 WO2018036607A1 (de) | 2016-08-22 | 2016-08-22 | Polymermaterial umfassend ein oder mehrere unterschiedliche dotierungselemente, verwendungen und herstellverfahren |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019534930A JP2019534930A (ja) | 2019-12-05 |
JP6792079B2 true JP6792079B2 (ja) | 2020-11-25 |
Family
ID=56802480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019531531A Active JP6792079B2 (ja) | 2016-08-22 | 2016-08-22 | 1つまたは複数の異なるドーピング要素を含むポリマー材料、利用法、および製造方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190192560A1 (ja) |
EP (2) | EP3904440A1 (ja) |
JP (1) | JP6792079B2 (ja) |
AU (1) | AU2016421086B2 (ja) |
CA (1) | CA3034656C (ja) |
DK (1) | DK3500623T3 (ja) |
ES (1) | ES2881025T3 (ja) |
PL (1) | PL3500623T3 (ja) |
PT (1) | PT3500623T (ja) |
RU (1) | RU2720785C1 (ja) |
WO (1) | WO2018036607A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110656444A (zh) * | 2019-10-06 | 2020-01-07 | 武汉纺织大学 | 防静电羊毛角蛋白纤维无纺布及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0778026B2 (ja) * | 1988-12-30 | 1995-08-23 | 新田ゼラチン株式会社 | 皮膚用外用基剤 |
JPH03130413A (ja) * | 1989-10-17 | 1991-06-04 | Teijin Ltd | 芯鞘型複合磁性繊維及びそれを用いた磁性繊維集合体 |
RU2000680C1 (ru) * | 1991-03-01 | 1993-09-07 | Мареичев А.В., Капитонов В.И., Попов Г.П. | Материал дл защиты от воздействи электромагнитного излучени |
JP2582124Y2 (ja) * | 1992-02-26 | 1998-09-30 | 鐘紡株式会社 | 磁性を有する肌着 |
RU2102801C1 (ru) * | 1994-09-28 | 1998-01-20 | Анатолий Васильевич Мареичев | Материал для защиты от воздействия излучений |
JPH11155606A (ja) * | 1997-11-27 | 1999-06-15 | Maguekkusu:Kk | 靴の中敷き |
WO2001025514A1 (en) * | 1999-10-04 | 2001-04-12 | Insung Powdertech Co., Ltd. | Fibre and fabrics with magnetic material |
RU2370464C2 (ru) * | 2004-06-24 | 2009-10-20 | Бенек Ой | Способ легирования материала и легированный материал |
KR20060091901A (ko) * | 2005-02-16 | 2006-08-22 | 서헌규 | 건강 증진 기능을 갖는 코드형 탄성 재료의 제조방법 |
DE102007032821A1 (de) * | 2007-07-12 | 2009-01-15 | Nora Systems Gmbh | Schuh für medizinische Anwendungen |
JP2009035850A (ja) * | 2007-08-01 | 2009-02-19 | Kazunori Okawa | 着磁可能なフィラメント及び織物類 |
RU2410402C2 (ru) * | 2007-12-28 | 2011-01-27 | Александр Метталинович Тишин | Пористые материалы с внедренными наночастицами, способы их изготовления и применения |
WO2009151145A1 (ja) * | 2008-06-10 | 2009-12-17 | 宇部興産株式会社 | 新規なポリアミド樹脂組成物及びポリアミド樹脂含有製品 |
DE102009006941B4 (de) * | 2009-01-30 | 2013-01-10 | Otto Bock Healthcare Gmbh | Verwendung von fein verteilten Metallpartikeln in einem Material, einer Hautauflage und einem orthopädischen Artikel |
CN102462151B (zh) * | 2010-11-05 | 2016-05-11 | Hct亚洲有限公司 | 具有磁性细丝的刷子 |
JP2016042935A (ja) * | 2014-08-20 | 2016-04-04 | 株式会社徳重 | 靴用中敷 |
-
2016
- 2016-08-22 DK DK16757622.2T patent/DK3500623T3/da active
- 2016-08-22 ES ES16757622T patent/ES2881025T3/es active Active
- 2016-08-22 RU RU2019108069A patent/RU2720785C1/ru active
- 2016-08-22 JP JP2019531531A patent/JP6792079B2/ja active Active
- 2016-08-22 EP EP21173219.3A patent/EP3904440A1/de active Pending
- 2016-08-22 US US16/326,947 patent/US20190192560A1/en not_active Abandoned
- 2016-08-22 EP EP16757622.2A patent/EP3500623B1/de active Active
- 2016-08-22 CA CA3034656A patent/CA3034656C/en active Active
- 2016-08-22 PL PL16757622T patent/PL3500623T3/pl unknown
- 2016-08-22 PT PT167576222T patent/PT3500623T/pt unknown
- 2016-08-22 AU AU2016421086A patent/AU2016421086B2/en active Active
- 2016-08-22 WO PCT/EP2016/069816 patent/WO2018036607A1/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2019534930A (ja) | 2019-12-05 |
EP3500623A1 (de) | 2019-06-26 |
RU2720785C1 (ru) | 2020-05-13 |
EP3500623B1 (de) | 2021-05-12 |
EP3904440A1 (de) | 2021-11-03 |
PL3500623T3 (pl) | 2021-11-15 |
CA3034656C (en) | 2022-10-18 |
WO2018036607A1 (de) | 2018-03-01 |
US20190192560A1 (en) | 2019-06-27 |
AU2016421086B2 (en) | 2021-11-18 |
PT3500623T (pt) | 2021-08-09 |
ES2881025T3 (es) | 2021-11-26 |
DK3500623T3 (da) | 2021-08-09 |
CA3034656A1 (en) | 2018-03-01 |
AU2016421086A1 (en) | 2019-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5606329B2 (ja) | 創傷治療システムおよび方法 | |
Alvarez-Mejia et al. | Functional recovery in spinal cord injured rats using polypyrrole/iodine implants and treadmill training | |
KR20070105331A (ko) | 일산화질소를 포함하는 신경병증의 치료 장치, 방법 및용도 | |
JP2008231657A (ja) | ポリマー繊維組成物および方法 | |
BRPI0609157A2 (pt) | dispositivo para cuidado de feridas e uso do mesmo | |
Rajendran et al. | Hi-tech textiles for interactive wound therapies | |
JP6792079B2 (ja) | 1つまたは複数の異なるドーピング要素を含むポリマー材料、利用法、および製造方法 | |
CN109289054A (zh) | 一种特异靶向骨组织的plga-peg-zol载药纳米材料及其制备方法 | |
KR20120133048A (ko) | 안티셀룰라이트 캡슐이 혼입된 기능성 의류 | |
CN106510012A (zh) | 一种杀菌、促进血液循环的石墨烯保健袜及其制备方法 | |
JP2009127157A (ja) | 慢性頭痛の治療用及び/又は予防用素材、並びにその用途 | |
ES2773604A1 (es) | Material textil con microparticulas bioceramicas que emite en el infrarrojo lejano en cuatro longitudes de onda concretas simultaneamente | |
US20090280151A1 (en) | Fabric with active principles and relevant recharging method of the active principles | |
Ali | Non-woven barrier properties of external layer for wound matrix | |
Rajendran et al. | High performance textiles for wound care | |
Oltarzhevskaya et al. | Medical textile and hydrogel materials for targeted delivery of drugs in oncological practice | |
JPH04112822A (ja) | シート状材料およびそれを用いた保健衛生機能を有する製品 | |
Kangazi et al. | Biomedical applications of healthcare textiles | |
CN110064078A (zh) | 一种用于瘦身调理亚健康的溶脂液 | |
TWM654432U (zh) | 石墨烯保健鞋 | |
Pagni et al. | Boeck's sarcoidosis revealed at hemispherectomy in a case of infantile encephalopathy with epilepsy | |
CN108378454A (zh) | 一种具有降血糖功能的保健布鞋及制作方法 | |
RU2382640C1 (ru) | Способ лечения больных с гнойно-воспалительными заболеваниями нижних конечностей на фоне сахарного диабета | |
KR200374913Y1 (ko) | 나노 실버가 함유된 반창고 | |
CN108938782A (zh) | 一种活络筋骨磁疗中药巴布剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190418 |
|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20190418 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190815 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200529 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200616 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200910 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201013 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201105 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6792079 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |